Ajanta Pharma Ltd. Investor Presentation

Ajanta Pharma Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter
All Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Ajanta Pharma Ltd.
05 Feb 2020
2602.25
0.99%
pdf
logo
Ajanta Pharma Ltd.
05 Nov 2019
2602.25
0.99%
pdf
logo
Ajanta Pharma Ltd.
31 Jul 2019
2602.25
0.99%
pdf
logo
Ajanta Pharma Ltd.
30 Apr 2019
2602.25
0.99%
pdf
logo
Ajanta Pharma Ltd.
30 Jan 2019
2602.25
0.99%
pdf
logo
Ajanta Pharma Ltd.
31 Oct 2018
2602.25
0.99%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Pursuant to Regulation 46 SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are now attaching the presentation on results being circulated to the investors and analysts and uploaded on our website.
pdf
logo
Ajanta Pharma Ltd.
31 Jul 2018
2602.25
0.99%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
We refer to the Unaudited financial results for the third quarter ended 30th June, 2018 submitted to your office today. Pursuant to Regulation 46 SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are now attaching the presentation on results being circulated to the investors and analysts and uploaded on our website. Kindly take the same on your records and disseminate to your members.
pdf
logo
Ajanta Pharma Ltd.
02 May 2018
2602.25
0.99%
pdf
logo
Ajanta Pharma Ltd.
25 Jan 2018
2602.25
0.99%
Investor Presentation
BSE India
Pursuant to Regulation 46 SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are now attaching the presentation on results being circulated to the investors and analysts and uploaded on our website for Quarter ended 31st December, 2017. Kindly take the same on your records and disseminate to your members.
pdf
logo
Ajanta Pharma Ltd.
31 Oct 2017
2602.25
0.99%
Investor Presentation
BSE India
We refer to the Unaudited financial results for the second quarter and half year ended 30th September, 2017 submitted to your office today. Pursuant to Regulation 46 SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are now attaching the presentation on results being circulated to the investors and analysts and uploaded on our website. Kindly take the same on your records and disseminate to your members.
pdf